Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedOn 2026-03-19, Contacts/Locations and Study Status were added to the record history, affecting 40 items. A deletion entry from 2026-02-20 is also recorded in the history.SummaryDifference0.3%

- Check21 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check28 days agoChange DetectedA new revision entry v3.4.3 has been added to the history, and the previous v3.4.2 entry has been removed.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history now includes additions of Contacts/Locations and Study Status sections, expanding visibility of trial contact information and the current study status.SummaryDifference0.3%

- Check57 days agoChange DetectedA new site revision (v3.4.2) was added to the record history, and the previous notices about government funding and revision v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check64 days agoChange DetectedThe page history adds a site-wide Notice about a lapse in government funding and a new release version (v3.4.1), replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.